Nu Skin Enterprises, Inc.NUSNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -13.76% | -8.82% | -12.66% | -12.06% | -15.33% |
| Gross Profit Growth | +3.15% | -20.79% | -16.02% | -13.49% | -14.84% |
| EBITDA Growth | +0.00% | -233.47% | +466.17% | +0.00% | -13.17% |
| Operating Income Growth | +0.00% | -430.46% | -212.25% | +0.00% | +18.71% |
| Net Income Growth | +0.00% | -595.81% | +0.00% | +0.00% | +105.72% |
| EPS Growth | +0.00% | -586.67% | +0.00% | +0.00% | +105.88% |
| EPS Diluted Growth | +0.00% | -586.67% | +0.00% | +0.00% | +100.00% |
| Weighted Average Shares Growth | -0.30% | +0.61% | +0.46% | -0.50% | -0.62% |
| Weighted Average Shares Diluted Growth | -0.25% | +0.47% | +1.59% | -0.38% | +1.16% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -38.40% | -52.40% | -88.28% | -30.10% | -12.57% |
| Free Cash Flow Growth | -41.63% | -60.92% | +0.00% | -16.96% | -23.08% |
| Receivables Growth | -10.92% | -13.48% | -15.61% | -16.56% | -28.95% |
| Inventory Growth | -14.88% | -32.05% | -28.79% | -26.07% | -27.95% |
| Asset Growth | -11.72% | -18.78% | -20.12% | -8.97% | -10.01% |
| Book Value per Share Growth | -13.76% | -21.22% | -7.36% | +15.38% | +13.85% |
| Debt Growth | -12.13% | -21.26% | -46.05% | -41.22% | -41.93% |
| R&D Expense Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -11.11% | -12.26% | -16.67% | -17.09% | -17.00% |